ZiP started pre-clinical testing of its SARS-CoV-2 test system at Royal Melbourne Hospital with the Victorian Infectious Diseases Reference Laboratory (VIDRL) in early June 2020. Pre-clinical testing is being conducted to complete commercial development of the system.
ZiP is planning to apply for Therapeutic Goods Administration, TGA approval for its SARS-CoV-2 test systems with validation of its at scale production facilities.
Comments